BG105256A - Muscarinic agonists and antagonists - Google Patents

Muscarinic agonists and antagonists

Info

Publication number
BG105256A
BG105256A BG105256A BG10525601A BG105256A BG 105256 A BG105256 A BG 105256A BG 105256 A BG105256 A BG 105256A BG 10525601 A BG10525601 A BG 10525601A BG 105256 A BG105256 A BG 105256A
Authority
BG
Bulgaria
Prior art keywords
antagonists
muscarinic agonists
present
compounds
muscarinic
Prior art date
Application number
BG105256A
Other languages
Bulgarian (bg)
English (en)
Inventor
Gurmit Grewal
Anna Toy-Palmer
Xiong CAY
George Latham
Original Assignee
Ucb S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S.A. filed Critical Ucb S.A.
Publication of BG105256A publication Critical patent/BG105256A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
BG105256A 1998-08-18 2001-02-14 Muscarinic agonists and antagonists BG105256A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
BG105256A true BG105256A (en) 2001-11-30

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105256A BG105256A (en) 1998-08-18 2001-02-14 Muscarinic agonists and antagonists

Country Status (30)

Country Link
US (5) US6093724A (id)
EP (1) EP1112272B1 (id)
JP (1) JP2002523416A (id)
KR (1) KR20010072784A (id)
CN (1) CN1312812A (id)
AR (1) AR020199A1 (id)
AT (1) ATE227724T1 (id)
AU (1) AU750566B2 (id)
BG (1) BG105256A (id)
BR (1) BR9913072A (id)
CA (1) CA2340946A1 (id)
CO (1) CO5130018A1 (id)
DE (1) DE69903961T2 (id)
EE (1) EE200100096A (id)
ES (1) ES2191455T3 (id)
HK (1) HK1038918A1 (id)
HU (1) HUP0103203A3 (id)
ID (1) ID27544A (id)
IL (1) IL141050A0 (id)
IS (1) IS5827A (id)
NO (1) NO20010804L (id)
NZ (1) NZ509762A (id)
PE (1) PE20000988A1 (id)
PL (1) PL346247A1 (id)
RU (1) RU2219179C2 (id)
SK (1) SK1892001A3 (id)
TR (1) TR200100462T2 (id)
WO (1) WO2000011001A1 (id)
YU (1) YU13301A (id)
ZA (1) ZA200100978B (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU30603A (sh) * 2000-10-19 2006-05-25 Pfizer Products Inc. Derivati premošćenog piperazina
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
US8163914B2 (en) 2007-03-23 2012-04-24 Abbott Laboratories Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
CN101641357B (zh) * 2007-03-23 2013-09-18 Abbvie公司 4-取代的氮杂金刚烷衍生物及其使用方法
MX2011014019A (es) * 2009-06-19 2012-02-22 Abbott Lab Derivados de diazahomoadamantano y sus metodos de uso.
PL3061821T3 (pl) 2009-07-22 2020-01-31 PureTech Health LLC Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
SG188307A1 (en) 2010-09-23 2013-04-30 Abbvie Inc Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2019126559A1 (en) * 2017-12-20 2019-06-27 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
BR112021005802B1 (pt) 2018-09-28 2022-02-15 Karuna Therapeutics, Inc Composição farmacêutica oral

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
EP0563036A1 (en) * 1990-12-21 1993-10-06 Merck Sharp & Dohme Ltd. 4-azatricyclo 2.2.1.0?2,6 ]heptanes and pharmaceutical compositions
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
RU2162469C2 (ru) * 1995-11-02 2001-01-27 Ньюросерч А/С Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
NO20010804L (no) 2001-04-11
IS5827A (is) 2001-01-26
EE200100096A (et) 2002-06-17
NO20010804D0 (no) 2001-02-16
PE20000988A1 (es) 2000-09-30
EP1112272B1 (en) 2002-11-13
ZA200100978B (en) 2002-02-05
IL141050A0 (en) 2002-02-10
WO2000011001A1 (en) 2000-03-02
HUP0103203A3 (en) 2002-10-28
NZ509762A (en) 2002-12-20
KR20010072784A (ko) 2001-07-31
US6323194B1 (en) 2001-11-27
ATE227724T1 (de) 2002-11-15
US6423842B1 (en) 2002-07-23
DE69903961T2 (de) 2003-07-03
BR9913072A (pt) 2001-05-15
CO5130018A1 (es) 2002-02-27
US6093724A (en) 2000-07-25
AU5775899A (en) 2000-03-14
PL346247A1 (en) 2002-01-28
CN1312812A (zh) 2001-09-12
TR200100462T2 (tr) 2001-09-21
SK1892001A3 (en) 2001-11-06
AR020199A1 (es) 2002-05-02
YU13301A (sh) 2005-06-10
EP1112272A1 (en) 2001-07-04
HUP0103203A2 (hu) 2002-01-28
CA2340946A1 (en) 2000-03-02
ES2191455T3 (es) 2003-09-01
US6251916B1 (en) 2001-06-26
AU750566B2 (en) 2002-07-25
DE69903961D1 (de) 2002-12-19
ID27544A (id) 2001-04-12
US6555550B1 (en) 2003-04-29
RU2219179C2 (ru) 2003-12-20
HK1038918A1 (zh) 2002-04-04
US20020045617A1 (en) 2002-04-18
JP2002523416A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
BG105256A (en) Muscarinic agonists and antagonists
DE69905170D1 (en) Thiazolopyrimidinderivate
NZ330667A (en) Use of substituted 2,4-imadazolidinedione compounds as analgesics
ZA979961B (en) 5-HT1F agonists
IL157093A0 (en) 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
HUP9800417A3 (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-indoles and 5-substituted-3-(piperidin-4-yl)-1h-indoles, their use as new 5-ht agonists, pharmaceutical compositions containing these compounds
HUP0104696A3 (en) Pharmaceutical composition containing 5ht1 receptor agonists and metoclopramide for the treatment of migraine
BG104916A (en) Calcilytic compounds
SE9802937D0 (sv) Novel compounds
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
IL117209A0 (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
BG105539A (en) Eletriptan hydrobromide monohydrate
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
PL340459A1 (en) Agonists of 5ht1f
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
YU58600A (sh) Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola
IL139144A0 (en) Mycobacterial inhibitors
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
MD980129A (en) Antiherpetic remedy
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora